title: High incidence of chromosome 1 abnormalities in a series of 27 renal oncocytomas: cytogenetic and fluorescence in situ hybridization studies.
abstract: BACKGROUND
  It has recently been shown by cytogenetics that there is a high incidence of chromosome 1 abnormalities in renal oncocytomas.
  
  
  OBJECTIVE
  To confirm the cytogenetic results by fluorescence in situ hybridization (FISH) analysis.
  
  
  METHODS
  Nine additional cytogenetic analyses were added to those reported in our recent study, with a total of 27 tumors studied, which makes it the largest series of renal oncocytomas studied to date by cytogenetics and/or FISH. We used the LSI 1p36/LSI 1q25 Dual Color Probe Set to make the analyses.
  
  
  RESULTS
  In this study, combined cytogenetics and FISH showed loss of chromosome arm 1p1 in 48% of renal oncocytomas. By FISH, deletion of 1p36.3 was observed in 59% of renal oncocytomas, whereas by cytogenetics, abnormality in chromosome 1 was seen in 32% of tumors. However, the incidence of chromosome 1 abnormalities among 9 bilateral tumors was much higher than in single tumors (88% vs 28%, respectively). Loss of only the 1p36.3 site occurred in 2 renal oncocytomas with translocation of chromosome 1, as shown by cytogenetics. Concordance between the 2 techniques, when they were used simultaneously to detect chromosome 1p1 abnormality, was 82%.
  
  
  CONCLUSIONS
  This study further confirmed our prior results demonstrating the widespread occurrence of chromosome 1 abnormalities in renal oncocytomas. Although no abnormalities in chromosome 1 in tumors with normal karyotypes were detected by FISH using the current set of probes, a much higher incidence of such abnormalities was found in bilateral tumors, suggesting that genetic alterations related to the development of renal oncocytoma reside in this region.
authors.affiliation: Department of Pathology, Loyola University Medical Center, Maywood, Ill 60153, USA.
authors.forename: Gladell P
authors.initials: GP
authors.lastname: Paner
authors.forename: Valerie
authors.initials: V
authors.lastname: Lindgren
authors.forename: Kris
authors.initials: K
authors.lastname: Jacobson
authors.forename: Kathleen
authors.initials: K
authors.lastname: Harrison
authors.forename: Ying
authors.initials: Y
authors.lastname: Cao
authors.forename: Steve C
authors.initials: SC
authors.lastname: Campbell
authors.forename: Robert C
authors.initials: RC
authors.lastname: Flanigan
authors.forename: Maria M
authors.initials: MM
authors.lastname: Picken
mesh_terms: D018249:Adenoma, Oxyphilic / Q000209:etiology / Q000235:genetics*; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002869:Chromosome Aberrations; D002872:Chromosome Deletion; D002878:Chromosomes, Human, Pair 1 / Q000235:genetics*; D020732:Cytogenetic Analysis; D005260:Female; D006801:Humans; D017404:In Situ Hybridization, Fluorescence; D015994:Incidence; D007621:Karyotyping; D007680:Kidney Neoplasms / Q000209:etiology / Q000235:genetics*; D008297:Male; D008875:Middle Aged